Yimin Mao - Concepedia

Author

Yimin Mao

Renji Hospital ORCID

Also Known As

Dan Liu, Mao Yimin, Mao, Yimin, Silvia Sookoian, Xiaokai Wang, Y M Mao, Y. M. Mao, Y. Mao, Yaoyao Mao, Yi Min Mao

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

Renji Hospital Shanghai Jiao Tong University Capital Medical University Fudan University Mengchao Hepatobiliary Hospital

About

Yimin Mao is an author at Renji Hospital specializing in medicine, pharmacology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	1.5K
2	Health Sciences	4	4	291
3	Engineering	1	1	65
4	Biochemistry	1	1	167
5	Civil Engineering	1	1	65

Yimin Mao

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, The Lancet UrologySurgical OncologyGastrointestinal OncologyMedicineBiliary Cancer	2023	891
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China Tao Shen, Yingxia Liu, Jia Shang, Gastroenterology	2019	588
Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury Baolin Niu, Xiaohong Lei, Qingling Xu, Cell Biology and Toxicology InflammationBiochemistryMitochondrial FunctionMedicineLiver Physiology	2021	167
Prediction of significant fibrosis in HBeAg‐positive patients with chronic hepatitis B by a noninvasive model† Minde Zeng, Lungen Lu, Yimin Mao, Hepatology	2005	163
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines Harshad Devarbhavi, Guruprasad P. Aithal, Sombat Treeprasertsuk, Hepatology International Asia Pacific AssociationHepatologyLiver PhysiologyPharmacologyHepatology Inflammation	2021	152
Sofosbuvir–velpatasvir for treatment of chronic hepatitis C virus infection in Asia: a single-arm, open-label, phase 3 trial Lai Wei, Seng Gee Lim, Qing Xie, The Lancet. Gastroenterology & hepatology HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy	2018	120
Simpler score of routine laboratory tests predicts liver fibrosis in patients with chronic hepatitis B Kun Zhou, Chunfang Gao, Yunpeng Zhao, Journal of Gastroenterology and Hepatology	2010	117
Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study. Shukui Qin, Zhendong Chen, Weijia Fang, Journal of Clinical Oncology PharmacotherapyPembro Vs PlaceboPre-clinical PharmacologyKeynote-394 StudyClinical Trials	2022	109
Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial Lungen Lu, Minde Zeng, Yimin Mao, World Journal of Gastroenterology	2003	84
A double-blind randomized trial of adefovir dipivoxil in Chinese subjects with HBeAg-positive chronic hepatitis B Minde Zeng, Yimin Mao, Guang-bi Yao, Hepatology	2006	72

Page 1